Cerus | CERS - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Cerus USD 33.33M 8.66M 2024-12
GRIFOLS EUR 686.84M 56.95M 2025-12
Haemonetics USD 202.39M 7.64M 2025-12
Neogen USD 99M 7.7M 2025-12
OraSure Technologies USD 11.34M 435K 2025-12
Plus Therapeutics 1.37M 30K 2025-12
Quidel USD -91.8M 366.6M 2026-03
Rockwell Medical USD 4.55M 1.49M 2024-06
STAAR Surgical USD 43.74M 34.13M 2025-12
Terumo JPY 149.02B 4.17B 2026-03
Utah Medical Products USD 5.8M 450K 2024-09